Daniel Keating has left Hogan Lovells after two decades to join Wilson Sonsini Goodrich & Rosati in Washington, D.C.

Until Aug. 24, Keating was a partner in Hogan Lovells’ corporate and M&A groups. He started work at Wilson Sonsini on Monday as a partner in its corporate practice and as a member of the global generic pharmaceutical industry group. Keating said, “it’s not clear” whether any others from Hogan Lovells will follow his lead to Wilson Sonsini.